Horwich A, Nicholls E J, Hendry W F
Testicular Tumour Unit, Royal Marsden Hospital, Sutton.
Br J Urol. 1988 Jul;62(1):79-81. doi: 10.1111/j.1464-410x.1988.tb04272.x.
Seminal analysis was performed within 2 months of orchiectomy on 97 patients with clinical Stage I malignant testicular teratoma managed by surveillance following orchiectomy. Relapse of malignant disease occurred in 28% of 47 patients with a sperm count less than 10 X 10(6)/ml and in 32% of 50 patients with a sperm count greater than or equal to 10 X 10(6)/ml. Of 11 patients with azoospermia, 4 relapsed and 1 developed contralateral testicular germ cell tumour. Of 35 patients with malignant teratoma undifferentiated the relapse rate was 68% in 16 patients with a sperm count less than 10 X 10(6)/ml and 42% in 19 patients with a sperm count greater than or equal to 10 X 10(6)/ml. It was concluded that sperm count analysis is non-contributory in estimating the risk of relapse in clinical Stage I teratoma.
对97例经睾丸切除术后接受监测的临床I期恶性睾丸畸胎瘤患者,在睾丸切除术后2个月内进行了精液分析。47例精子计数低于10×10⁶/ml的患者中,28%出现恶性疾病复发;50例精子计数大于或等于10×10⁶/ml的患者中,32%出现复发。11例无精子症患者中,4例复发,1例发生对侧睾丸生殖细胞肿瘤。35例未分化恶性畸胎瘤患者中,16例精子计数低于10×10⁶/ml的患者复发率为68%,19例精子计数大于或等于10×10⁶/ml的患者复发率为42%。得出的结论是,精子计数分析对估计临床I期畸胎瘤的复发风险没有帮助。